NasdaqGM - Delayed Quote USD

AB Core Bond ETF (EYEG)

34.81 +0.08 (+0.23%)
At close: April 23 at 4:00 PM EDT
Loading Chart for EYEG
DELL
  • Previous Close 34.74
  • Open 34.81
  • Bid 34.72 x 100
  • Ask 34.87 x 100
  • Day's Range 34.81 - 34.81
  • 52 Week Range 34.52 - 36.24
  • Volume 90
  • Avg. Volume 381
  • Net Assets 24.96M
  • NAV 34.73
  • PE Ratio (TTM) --
  • Yield --
  • YTD Daily Total Return -2.05%
  • Beta (5Y Monthly) 0.00
  • Expense Ratio (net) 0.30%

The fund pursues its objective by investing, under normal circumstances, at least 80% of its net assets, including any borrowings for investment purposes, in investment grade fixed-income securities of corporate issuers. Corporate issuers may include corporate or other business entities in which a sovereign or governmental agency or entity may have, indirectly or directly, an interest, including a majority or greater ownership interest.

AllianceBernstein

Fund Family

Corporate Bond

Fund Category

24.96M

Net Assets

2023-12-12

Inception Date

Performance Overview: EYEG

Trailing returns as of 4/23/2024. Category is Corporate Bond.

YTD Return

EYEG
2.05%
Category
0.01%
 

1-Year Return

EYEG
0.00%
Category
4.69%
 

3-Year Return

EYEG
0.00%
Category
1.75%
 

People Also Watch

Related ETF News

Research Reports: EYEG

  • NEO: What does Argus have to say about NEO?

    NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $52.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • NEO: Raising target price to $52.00

    NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $52.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • NEO: Lowering target price to $50.00

    NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $50.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.

    Rating
    Price Target
     
  • NEO: Lowering target price to $55.00

    NEOGENOMICS INC has an Investment Rating of HOLD; a target price of $55.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.

    Rating
    Price Target
     

Related Tickers